StonvexLoading…
StonvexStonvexStonvexCore line items from RITM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $1.18B | $3.68B | $3.07B | $1.94B |
Operating Income | $380.90M | $752.83M | $790.13M | $516.36M |
Net Income | $284.04M | $622.26M | $697.83M | $476.63M |
EPS (Diluted) | $0.54 | $1.10 | $1.28 | $0.88 |
Total Assets | $47.94B | $39.72B | $36.79B | $36.00B |
Total Liabilities | $40.69B | $32.62B | $29.52B | $28.80B |
Cash & Equivalents | $1.14B | $1.29B | $1.22B | $1.37B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 483.48M | 483.23M | 483.21M | 483.32M |